‘Risks of Alzheimer’s Disease in Adults with Down Syndrome’ webinar and introduction to research study is March 29
Mar. 8, 2021—The Vanderbilt Kennedy Center and the Down Syndrome Association of Middle Tennessee will co-sponsor a webinar, “Risks of Alzheimer's Disease in Adults with Down Syndrome and Introduction to a Research Study,” on Monday, March 29, from 7 to 8 p.m. CT.
Jul. 23, 2020—VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease.
Vanderbilt, The Ohio State University developing ‘socially assistive robots’ to stem loneliness and encourage activity among aging
Jun. 18, 2020—Prestigious grant awarded to Nilanjan Sarkar, Vanderbilt researcher developing social robotics to stymie apathy among older adults.
Nov. 2, 2017—Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently.
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Mar. 2, 2017—Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains.
Dec. 27, 2016—Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
Oct. 29, 2015—Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.
Dec. 16, 2013—The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.
Nov. 25, 2013—Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
Dec. 20, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements last week during a celebration at the Student Life Center. “An endowed chair is the highest academic honor that a university can bestow on its faculty,” said University Provost and Vice Chancellor for Academic Affairs Richard McCarty, Ph.D. “It’s really...
Dec. 13, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center.